Investigator
Chunyang Jin
RESEARCH TRIANGLE INSTITUTE · funded by NIAAA, NINDS
- Companies
- 2
- Grants
- 2
- Non-dilutive funding
- $1.5M
- First award
- May 9, 2025
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 20, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- RESEARCH TRIANGLE INSTITUTEMomentum in another area
NeuroGrant-only
- RESEARCH TRIANGLE INSTITUTEMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Small molecule modulators of RXFP3 for alcohol use disorder
$902kSep 20, 2025NIAAARESEARCH TRIANGLE INSTITUTENIH RePORTER · 11228962 (opens the source filing in a new tab)
- R21
Development of GPR139 antagonists for the treatment of pain
$603kMay 9, 2025NINDSRESEARCH TRIANGLE INSTITUTENIH RePORTER · 11034348 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources